Announcements Trials
Browse Landscape

Phase

Phase 1 53Phase 1/2 39Phase 2 12Phase 3 3Phase 2/3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 18Thoracic 13Gastrointestinal 13Genitourinary 9Lymphoid 5Head & Neck 5Gynecologic 5Other hematologic neoplasm 4Plasma cell 3Other solid neoplasm 3Endocrine 2Classical hematology 2Dermatologic 1

Conditions

Pediatric Solid Tumor, Unspecified, Protocol Specific 1Mesothelioma, Malignant 1Mesothelioma 1Docetaxel 1

Interventions

Carboplatin 10Cisplatin 7Pemetrexed 6Vincristine 5Nivolumab 5Etoposide 4Topotecan 3Specimen Handling 3Ipilimumab 3Injections 3Doxorubicin 3Talc 2Radiotherapy 2Paclitaxel 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Filgrastim 2Drug Therapy 2Cyclophosphamide 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1sintilimab 1ranpirnase 1raltitrexed 1pertuzumab 1pembrolizumab 1onartuzumab 1iniparib 1durvalumab 1dostarlimab 1crofelemer 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Injections × Other solid neoplasm × Clear all
NCT04996017 2025-03-13

AtezoMeso

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Recruiting
162 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06208917 2024-01-17

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Sun Yat-sen University

Phase 3 Recruiting
376 enrolled
Other solid neoplasm

Pediatric Solid Tumor, Unspecified, Protocol Specific

NCT04889599 2022-01-11

A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours

Zhuhai Beihai Biotech Co., Ltd

Phase 3 Completed
46 enrolled
Other solid neoplasm

Docetaxel

Data powered by HemOnc (CC BY 4.0) Colophon âš¡